New findings could provide additional insight into the cause of glioblastoma and provide new options for personalized therapeutic treatments.
Using a new algorithm, researchers find the loss of the KLHL9 gene is a driving force behind glioblastoma brain cancer.
A new study provides a possible explanation as to what causes cognitive and memory problems associated with chemotherapy treatments.
According to a new study, a hormone which helps keep us alert also suppresses the spread of cancer.
Researchers discover why certain glioblastoma brain tumors are resistant to drugs.
Researchers report the antidepressant drug Rolipram could be used to effectively treat medulloblastoma brain cancer.
Researchers have discovered a way to diagnose brain cancer based on genetic markers found in junk DNA.
Targeting aPKC, a protein crucial for neurodevelopment, researchers report they can block multiple signaling pathways implicated in brain tumor growth.
Researchers report gliomas do not grow their own blood vessels.
Researchers discover glioblastoma brain tumor cells disrupt the blood brain barrier. The findings offer potential new avenues to treat brain cancer.
Researchers show SUMO family proteins are key to why glioblastoma tumors multiply uncontrollably.
Researchers have discovered a biomarker which predicts whether glioblastoma brain tumors will respond to chemotherapy.
Researchers shed new light on how glioma cells migrate in the brain and cause tumors.
Researchers have identified two oncogenes that drive the development of medulloblastoma brain cancer.
Researchers find high levels of progesterone can kill glioblastoma cells and inhibit brain tumor growth.